Introduction: Addiction Doesn’t Start With a Substance
Most people, when they think about why someone develops an addiction, focus on the substance. The drug. The drink. The behaviour. What it is and what it does. But the substance is rarely where the story starts.
The more clinically accurate and practically useful question is not what someone is using — it is why the substance became necessary. What function is it serving? What is it doing that nothing else was doing? What was happening before it arrived?
Decades of research in neuroscience, developmental psychology, trauma theory, and addiction medicine have produced a clear and consistent answer: addiction is most often a response to something that happened before the substance. It is, in many cases, a solution to a problem — an imperfect, ultimately destructive solution, but a solution nonetheless. Understanding the problem is what makes treatment effective. Treating only the solution — the substance — is why so many approaches fail.
This pillar covers the real causes of addiction: the neurobiological mechanisms, the role of trauma and adverse experiences, the relationship between mental health and substance use, and the social and environmental factors that create vulnerability. It is foundational content for anyone trying to understand why addiction happened — and what effective treatment therefore needs to address.
To understand what treatment looks like once you have this foundation, read our Complete Guide to Addiction and our guide on how rehab works.
The Neuroscience of Addiction: What the Brain Is Actually Doing
Addiction is not a character flaw, a moral failure, or a lack of willpower. This is not a compassionate framing layered over a behaviour problem. It is an accurate description of the neurobiological reality — one that changes both how we understand addiction and what effective treatment looks like.
The Reward System and Dopamine
At the centre of addiction is the brain’s reward system — a network of structures, including the nucleus accumbens and the ventral tegmental area, that evolved to motivate survival behaviours by producing dopamine in response to things the organism needs: food, water, sex, social connection.
Addictive substances — alcohol, opioids, methamphetamine, cocaine, cannabis — act on this system artificially and powerfully. They flood the reward circuits with dopamine at levels that natural rewards cannot produce. The brain registers this as extraordinarily significant. It forms strong memories around the substance and the circumstances associated with it. And it begins to adapt.
The adaptation is the problem.
With repeated use, the brain responds to the artificial dopamine flood by downregulating its own dopamine production and reducing receptor sensitivity. The result: natural rewards — food, connection, achievement, pleasure — produce less and less of a response. The substance, which once produced euphoria, now produces something closer to normal function. The person is no longer using to feel good. They are using to feel at all.
This is tolerance and dependence at the neurobiological level — and it explains why “just stop” is not a clinically meaningful instruction for someone in this state. The brain has been physically reorganised around the substance.
The Prefrontal Cortex and Impaired Control
Chronic substance use does not only affect the reward system. It produces significant changes in the prefrontal cortex — the region responsible for planning, impulse control, decision-making, risk assessment, and the ability to weigh long-term consequences against immediate gratification.
The National Institute on Drug Abuse (NIDA) describes addiction as fundamentally a disorder of this executive function system. The addicted brain’s capacity to override the pull of immediate reward in favour of long-term goals is genuinely compromised — not as an excuse, but as a neurological reality demonstrated in imaging studies.
This is why people continue to use despite clear consequences, despite genuine intention to stop, despite the harm they can see unfolding. The circuit that is supposed to intervene is impaired.
The Stress System and Negative Reinforcement
There is a third neurobiological driver of addiction that is less commonly discussed but equally important: the stress system.
Chronic substance use dysregulates the brain’s stress response — the HPA axis (hypothalamic-pituitary-adrenal axis) and associated neurochemistry. Over time, the brain’s baseline stress level rises, and the discomfort of not using becomes a powerful driver of use in its own right. At this stage, the person is no longer primarily using to feel good. They are using to escape the discomfort of not using — a negative reinforcement cycle that is extraordinarily difficult to break without addressing the neurochemical underpinning.
This stress system dysregulation is also why withdrawal is so uncomfortable, why cravings are triggered by stress, and why untreated anxiety and depression are among the most powerful relapse risk factors.
Trauma: The Most Underestimated Cause of Addiction
Of all the factors that contribute to addiction, trauma is arguably the most important and the most consistently underestimated — in popular understanding, in clinical settings, and in the experience of people who are struggling.
The ACE Study
The Adverse Childhood Experiences (ACE) Study — conducted by the Centers for Disease Control and Prevention and Kaiser Permanente, and now one of the most cited bodies of research in public health — provides the most compelling epidemiological evidence for the trauma-addiction connection.
The study surveyed more than 17,000 adults about their exposure to ten categories of adverse childhood experiences: physical, emotional, and sexual abuse; physical and emotional neglect; household dysfunction including witnessing domestic violence, living with a substance-using household member, household mental illness, parental separation, and incarcerated household members.
The findings were stark. Each additional ACE category was associated with a substantially elevated risk of a broad range of health outcomes — including alcohol and drug use disorders. People with four or more ACEs had a 700% greater likelihood of alcoholism and a 4,600% greater likelihood of IV drug use compared to those with no ACEs.
These are not marginal statistical associations. They are among the largest effect sizes in public health research — and they provide a clear answer to the question of why some people develop addiction while others who use the same substances do not.
Why Trauma Drives Substance Use
The mechanism is not mysterious once understood. Trauma — particularly childhood trauma — produces lasting changes in the developing brain:
Neurobiological changes — Chronic early stress dysregulates the HPA axis, alters amygdala reactivity (making the person more sensitive to threat), impairs prefrontal cortex development (reducing capacity for emotional regulation and impulse control), and affects the development of the reward system itself.
Emotional dysregulation — Trauma disrupts the capacity to identify, tolerate, and regulate emotional states. Overwhelming emotions — grief, rage, shame, terror, emptiness — become chronic states that demand management. Substances provide rapid, reliable, powerful regulation of emotional experience. They work — in the short term.
Dissociation and numbing — One of the brain’s responses to overwhelming experience is dissociation — a disconnection from internal experience. Alcohol and opioids in particular produce a numbing, dissociative effect that provides relief from states that feel unbearable. For someone whose baseline experience is shaped by unresolved trauma, this relief is not recreational — it is functional.
Shame and self-concept — Trauma, particularly in childhood, produces core beliefs about the self: that one is worthless, unlovable, fundamentally broken, or responsible for what happened. Substance use provides temporary relief from these beliefs. It also, in due course, confirms them — adding layers of shame that make help-seeking harder and recovery more complex.
The Blue Knot Foundation, Australia’s national centre of excellence for complex trauma, identifies the trauma-addiction connection as one of the most clinically significant in the AOD field — and consistently advocates for trauma-informed practice as foundational to any effective addiction treatment approach.
Mental Health and Addiction: The Bidirectional Relationship
Addiction and mental health conditions do not simply co-occur — they are deeply, neurobiologically intertwined in ways that make treating one without the other clinically inadequate.
The Scale of Co-Occurrence
The Australian Institute of Health and Welfare (AIHW) reports that mental health conditions are present in the majority of Australians seeking alcohol and other drug treatment. The most common co-occurring conditions include:
- Anxiety disorders — generalised anxiety, social anxiety, panic disorder, PTSD
- Depressive disorders — major depression, dysthymia, bipolar depression
- PTSD — particularly prevalent in veterans, abuse survivors, and those with complex trauma histories
- ADHD — associated with significantly elevated rates of substance use disorder
- Borderline Personality Disorder — high rates of co-occurrence with alcohol and self-medication patterns
- Psychotic disorders — particularly cannabis-induced psychosis and stimulant-related presentations
The Bidirectional Loop
The relationship between mental health and addiction runs in both directions simultaneously:
Mental health conditions drive substance use — Anxiety is managed with alcohol. Depression is lifted with stimulants. ADHD is self-medicated with cocaine. Sleep disruption is managed with cannabis or benzodiazepines. Trauma symptoms are numbed with opioids. In each case, the substance provides genuine, short-term relief for a genuine, undertreated condition.
Substance use worsens mental health — Over time, alcohol worsens anxiety and depression. Cannabis elevates psychosis risk. Methamphetamine produces lasting neurological changes that compound depression. Benzodiazepines worsen anxiety between doses. The very conditions the substance was managing become more severe — driving increased use in a tightening spiral.
Withdrawal mimics and exacerbates mental health symptoms — Alcohol withdrawal produces anxiety, insomnia, and depression. Cannabis withdrawal produces irritability and anxiety. Stimulant withdrawal produces profound depression. For someone with pre-existing mental health conditions, withdrawal can be severely destabilising — and is one of the most common proximate causes of relapse in early recovery.
The Clinical Implication: Integrated Dual Diagnosis Treatment
The bidirectional nature of the mental health-addiction relationship makes integrated treatment — addressing both conditions simultaneously, through a coordinated clinical team — not a premium option, but the standard of care.
Treating addiction without the co-occurring mental health condition is like treating the infection without the immune deficiency driving it. Symptoms may reduce temporarily, but the underlying vulnerability remains — and drives relapse.
HARP’s three-pronged clinical model is built around this reality. Treatment is delivered through three integrated clinical roles:
The Addiction Specialist and Programme Facilitator — leads the 5i Recovery Curriculum, delivering neuroscience-based psychoeducation, CBT-informed behavioural restructuring, and relapse prevention architecture. This role addresses the cognitive and behavioural dimensions of addiction.
The Trauma Specialist Psychologist — works at the emotional and nervous system level, integrating trauma-informed psychology, DBT emotion regulation, somatic awareness, attachment repair, and fight/flight/freeze/fawn tracking. This role addresses the emotional and trauma-driven roots of substance use.
The AOD Specialist Counsellor — provides substance-specific clinical intervention, relapse prevention in real-world scenarios, and practical recovery planning.
These three pillars operate as an integrated clinical team — not as separate referrals in separate systems. Read more: dual diagnosis and addiction recovery.
Stress: The Everyday Driver of Addiction
Trauma represents the acute, often childhood-based end of the stress spectrum. But chronic, ongoing stress — the kind that accumulates through work pressure, financial strain, relationship conflict, caregiving, social isolation, and a culture of relentless demand — is one of the most significant and least glamorous drivers of substance use disorder.
How Chronic Stress Drives Substance Use
The neurobiological relationship between chronic stress and addiction is well-established. Cortisol — the primary stress hormone — acts on dopamine pathways, reducing natural reward responsiveness and increasing the salience of substance-related cues. In plain terms: chronic stress makes natural pleasures less satisfying and substances more compelling.
NIDA identifies stress as one of the most powerful triggers for both initial substance use and relapse in individuals with established addiction. This is not a psychological insight — it is a neurobiological one. Stress directly activates the same circuits that addiction activates.
The cultures most associated with substance use disorder in Australia — high-pressure professional environments, FIFO work, hospitality, elite sport, creative industries — are also the cultures most characterised by chronic, unmanaged stress. This is not coincidental.
The Social Stress Model
A particularly important model for understanding stress and addiction is the social stress model, which identifies the role of social defeat, stigma, marginalisation, and lack of social connectedness as primary drivers of substance use disorder in vulnerable populations.
Dr Gabor Maté, whose work on trauma and addiction draws on both clinical experience and neuroscience, frames addiction as fundamentally about disconnection — from self, from others, from meaning. The opposite of addiction, in this framework, is not sobriety. It is connection.
This framing is supported by considerable research, including the famous Rat Park experiments conducted by Bruce Alexander in the late 1970s, which demonstrated that rats in enriched social environments with ample connection chose not to use morphine-laced water, while isolated rats in barren cages self-administered compulsively. The environment — social, relational, meaningful — determined drug use behaviour more than the drug itself.
The social stress model explains why social disconnection, loneliness, grief, and relational rupture are among the most common triggers for both onset and relapse.
The Biopsychosocial Model: Understanding All the Causes Together
No single factor causes addiction. The biopsychosocial model — now the standard clinical framework in Australian and international addiction medicine — recognises that substance use disorders arise from the intersection of:
Biological factors:
- Genetic predisposition (heritability of addiction is estimated at 40–60%)
- Neurobiological vulnerability — differences in dopamine receptor density, stress system reactivity, and prefrontal cortex development
- Age of first use — adolescent brains are significantly more vulnerable to addiction than adult brains, as the prefrontal cortex is not fully developed until the mid-twenties
- Co-occurring neurological conditions including ADHD and traumatic brain injury
Psychological factors:
- Trauma history and ACE score
- Attachment style — insecure attachment in early life is associated with elevated risk of substance use disorder
- Core beliefs and schema — deep beliefs about self-worth, safety, and belonging that were formed in early experiences
- Emotional regulation capacity — the ability to tolerate, name, and manage difficult internal states without externalising them
- Mental health conditions, including anxiety, depression, PTSD, and personality disorders
Social and environmental factors:
- Family history of addiction
- Peer group norms around substance use
- Access to substances in the home environment
- Socioeconomic disadvantage and adversity
- Occupational culture and workplace stress
- Social connectedness and quality of relationships
- Community belonging and cultural identity
The biopsychosocial model is explicitly embedded in HARP’s 5i Curriculum — particularly in the Impartiality module, which introduces clients to the biopsychosocial model as a framework for understanding their own addiction without reducing it to a single cause or a personal failing. Read more about the curriculum at the 5i Curriculum explained.
Genetic Vulnerability: The Role of Family History
The heritability of addiction is one of the most robust findings in behavioural genetics. Twin studies, adoption studies, and molecular genetic research consistently estimate that genetic factors account for approximately 40–60% of the variance in addiction risk across substances.
This does not mean that addiction is genetically determined — it means that genetic factors influence the brain systems (dopamine reward sensitivity, stress reactivity, impulse control) that, in the context of exposure to substances and stressors, contribute to the development of addiction.
The most clinically relevant implication: a family history of addiction is a significant risk factor and should inform both prevention efforts and the clinical approach to treatment. It is not destiny. It is information.
Why Willpower Alone Is Never Enough
One of the most damaging and persistent misconceptions about addiction is that it is primarily a failure of willpower — that people who develop addiction simply did not want to stop badly enough.
The neurobiological evidence — the prefrontal cortex changes, the reward system dysregulation, the stress system dysregulation, the deep conditioning of memory and craving — makes clear that this is not accurate. And the psychological and social evidence — the trauma histories, the co-occurring mental health conditions, the social isolation, the unmet developmental needs — makes clear that even if the will were there, it would not be enough.
Effective treatment addresses the neurobiological, psychological, and social dimensions of addiction simultaneously. It does not demand willpower as a prerequisite. It builds the neurological, emotional, and relational capacity that makes recovery possible — and then sustainable.
This is the clinical position that HARP’s entire model is built around. The 5i Curriculum does not assume willpower. It builds what willpower was supposed to deliver. For more on how that process unfolds in practice, read our addiction recovery guide.
Frequently Asked Questions
Is addiction genetic or environmental? Both — and the interaction between them is what matters most. Genetic factors account for approximately 40–60% of addiction risk, influencing the brain systems that determine reward sensitivity, stress reactivity, and impulse control. Environmental factors — trauma, stress, family history, peer influence, access to substances — shape whether and how that genetic vulnerability is expressed. Neither alone predicts addiction; together, they create risk profiles that treatment needs to address holistically.
Does trauma always cause addiction? No — but the statistical relationship is among the strongest in addiction research. The ACE Study demonstrated dose-response associations between adverse childhood experiences and alcohol and drug use disorders. Many people with significant trauma histories do not develop addiction; many people with addiction have no identified trauma. What trauma does is substantially elevate risk — and when addiction is present alongside unresolved trauma, effective treatment must address both.
Can addiction develop without mental health problems? Yes, though co-occurring mental health conditions are present in the majority of people seeking treatment. Substance use disorders can develop primarily through social exposure, genetic vulnerability, and escalating recreational use — without an identifiable mental health condition driving the pattern. However, where mental health conditions are present, they must be addressed simultaneously for treatment to be effective.
Why do some people get addicted and others don’t, even when using the same substances? The biopsychosocial model provides the most accurate answer: addiction risk is determined by the intersection of biological vulnerability (genetics, neurobiology, age of first use), psychological factors (trauma, attachment, emotional regulation capacity, mental health), and social and environmental factors (family history, peer norms, occupational culture, stress, social connectedness). The same substance in different people, in different contexts, with different histories, produces different outcomes — which is why addiction treatment must be individualised rather than standardised.
What is the most important thing to address in addiction treatment? The most important thing is the most important thing for this individual — which is why comprehensive assessment is the first step of any quality treatment programme. For many people, untreated trauma is the central driver. For others, an undiagnosed mental health condition. For others, chronic occupational stress and social isolation. Effective treatment identifies the root causes for the individual and addresses them directly — rather than targeting only the substance.
Sources
- NIDA — Drugs, Brains, and Behavior: The Science of Addiction
- Felitti VJ et al. — “Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: the Adverse Childhood Experiences (ACE) Study,” American Journal of Preventive Medicine (1998)
- AIHW — Alcohol and Other Drug Treatment Services in Australia, 2022–23
- Blue Knot Foundation — Understanding Complex Trauma and Its Relationship to Addiction
- Koob GF & Volkow ND — “Neurobiology of addiction: a neurocircuitry analysis,” The Lancet Psychiatry (2016)
- Alexander BK — “The myth of drug-induced addiction,” Senate of Canada submission (2001) — Rat Park research
- Maté G — In the Realm of Hungry Ghosts: Close Encounters With Addiction (2008)
- Alcohol and Drug Foundation (ADF) — Risk Factors for Addiction
- HARP — Dual Diagnosis and Addiction Recovery
- HARP — The 5i Curriculum
This article is reviewed for clinical accuracy and is intended for educational purposes only. It does not constitute medical advice. Please consult your GP, a registered psychologist, or a qualified AOD specialist for personalised guidance.
